Professor Rodney Phillips is Professor Emeritus at UNSW, Sydney and an Honorary Fellow of Oxford’s Pembroke College.

Rodney is an immunologist specialising in HIV and infectious diseases. He was Professor of Medicine and Head of Research and Associate Dean of Oxford University’s Division of Medical Sciences. He also served as Vice-Dean of Medical Sciences, Director of Peter Medawar Building for Pathogen Research and Co-Director of Oxford Martin Institute for Emerging Infections.

Rodney joined the Board in May 2017 and is a Member of the Risk Committee.

Kerry actively manages all peer-reviewed funding processes and procedure for TGI Australia by providing and coordinating pre-award support to all academics and researchers.

She oversees post-award management of successful research grant applications.

Professor Anne Mills is Deputy Director and Provost of the London School of Hygiene & Tropical Medicine, and Professor of Health Economics and Policy. She has degrees from Oxford University (MA), Leeds University (Diploma), and London University (PhD).

After two years as Overseas Development Institute Fellow and Economist in the Ministry of Health in Malawi, Professor Mills spent three years at the University of Leeds studying health planning in the NHS and moved to the LSHTM in 1979. She has researched and published widely in the fields of health economics and health systems in low- and middle-income countries and continues to be involved in research on financial protection in South Africa, Tanzania, India and Thailand. Professor Mills continues to be involved in supporting capacity development in health economics in universities, research institutes and governments.

She has been involved in numerous policy initiatives, including WHO's Commission on Macroeconomics and Health, and the 2009 High Level Taskforce on Innovative International Finance for Health Systems. Professor Mills has a CBE for services to medicine, is a Foreign Associate of the US Institute of Medicine, and a Fellow of the UK Academy of Medical Sciences. In 2009, she received the Prince Mahidol Award in the field of medicine. In 2013, she was elected a Fellow of the Royal Society, and in 2015 she was made a Dame in the Queen’s New Year’s Honours, for services to international health.

Devaki Nambiar is Program Director, Health Equity at the George Institute for Global Health India with appointments at the Manipal Academy of Higher Education, India, the University of New South Wales, Australia, and the Harvard TH Chan School of Public Health, USA.

She is a Health Policy and Systems Researcher (HPSRer) with over two decades of experience working in India and other Low- and Middle-Income Countries on decision-maker demand-driven research, postgraduate teaching in HPSR, as well as technical assistance with an emphasis on community action for health, social exclusion, health equity and health for all. She is a former Fulbright, Fogarty, and NIH scholar, and Fellow of the Wellcome Trust/Department of Biotechnology India Alliance. She advises the WHO on health inequality monitoring, national programme re-orientation, and guideline development to leave no one behind.

She serves on the Lancet-Chatham House Commission on Improving Population Health post COVID-19, the Lancet Commission on Sustainable Healthcare, and advises Lancet Commissions on Women and Cancer as well as on Reimagining India's Health System. She is a member of the People's Health Movement and the Medico Friends Circle. She also serves on the Board of Health Systems Global and the Research Advisory Board of the Institute of Public Health, Bengaluru, India. Dr. Nambiar received her doctorate in public health from the Johns Hopkins Bloomberg School of Public Health in 2009 and is a recipient of an Emerging Leader Award from the Royal Society for Tropical Medicine & Hygiene.

Dr Meena Thuraisingham is Founder and Principal at BoardQ and TalentInvest. She is also a Non-Executive Director of the Shared Value Project and Linden Art Gallery.

Meena has previously held executive roles at ANZ, including Global Head of Leadership and Talent and Head of Human Resources, Corporate & Institutional Bank. She has also held senior consultant roles with two global consulting firms.

Meena joined the Board in January 2018 and is a Member of the Risk Committee.

It is with great sadness that we share the news that Margie passed away in January 2026. Her vibrant and wide-reaching legacy continues, not least in the work to which she dedicated much of her life: on how to prevent unintentional injuries, particularly in resource-strapped countries.

While road injuries were the biggest issue, Margie's work also canvased other significant problems of drowning, burns and falls, and identified interventions that could save lives. Her research looked at what works, specifically in developing countries. It provided evidence on how to prevent injuries before they happen. But it also looked at the post-crash phase, working with nurses – who are the mainstay of healthcare provision in developing countries – to provide optimum treatment management. In some developing countries, traumatic injuries account for up to 70%-80% of the caseloads in emergency rooms. If you can stop these injuries upstream, there are enormous gains for healthcare systems, both financially and in terms of workforce needs.

Representing The George Institute for Global Health and South Africa, Margie was a member of the Commonwealth Road Safety Initiative Expert Panel and together with colleagues from Kenya and Canada led the data analysis for the reports being developed ahead of the 3rd Ministerial level meeting in Sweden in February 2020 and the CHOG meeting in Rwanda. She was also a member of the Academic Expert Group for this Ministerial meeting, a group responsible for making an independent and scientific assessment of the progress made during the Decade of Action for Road Safety. The Academic Expert Group will also recommend a road safety strategy for the period 2020-2030. Margie was also Chair of the Global Advisory Board for the Malawi Road Safety Research and Implementation Unit at the University of Malawi.

Amanda Henry is Program Head, Women’s Health at The George Institute for Global Health and Professor of Obstetrics in the Discipline of Women’s Health, School of Clinical Medicine, UNSW Medicine and Health. Her professional background is as a Clinical Academic and Obstetrician, with a clinical practice focussed on high-risk pregnancy at St George Hospital, Sydney.

Her research focus, including her current NSW Health Early-Mid Career Cardiovascular Fellowship, is on how pregnancy complications, particularly hypertensive disorders of pregnancy and gestational diabetes, can affect women’s lifelong health.  She leads a program of work on early intervention and improving systems of care to advance long-term cardiovascular health outcomes for women after a hypertensive pregnancy. Amanda is also an active researcher and research supervisor in the areas of high-risk pregnancy and pregnancy/postpartum clinical trials, and teaches pregnancy care to both undergraduate and postgraduate students. Amanda has a strong emphasis on collaborative research projects to drive improvements in Women’s Health, and in addition to her role with the George Institute, researches collaboratively with medical, midwifery and Allied Health colleagues, as well as consumer and community partners, both locally and nationally. She also promotes Women’s Health research translation into guidelines, policy and practice through her professional society roles, including as Councillor for the Royal Australian and New Zealand College of Obstetricians and Gynaecologists and the Society of Obstetric Medicine of Australia and New Zealand. 

Professor Jane Hirst is Chair in Global Women’s Health at The George Institute for Global Health, UK, and the School of Public Health at Imperial College. She is also Visiting Professor in Global Women's Health at the University of Oxford and Honorary Consultant Obstetrician, Oxford University Hospitals NHS Foundation Trust.

She is an active clinical researcher with projects focussed on global women’s health and investigating novel approaches to improve health care delivery. She has a particular interest in preventing cardiometabolic complications in women after high-risk pregnancy conditions such as gestational diabetes and preeclampsia.

Professor Hirst is a UKRI Future Leaders Fellow. Her Fellowship title is “Pregnancy as an opportunity to improve women’s lifelong health”. She is PI for the SMART Health Pregnancy trial in India. This trial is being conducted in two rural districts in two states, and is evaluating a community-based intervention and digital clinical decision support tool to improve screening, management and referral of high risk conditions during pregnancy and in the in first year after birth.

Associate Professor Brendon Neuen is Lead Global Clinical Trialist at The George Institute for Global Health, and Staff Specialist Nephrologist, Director of Kidney Trials, at Royal North Shore Hospital. He is the Co-Chair of SMART-C (SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium; www.SMART-C.net), Director of the CLARITY-IgAN Consortium (Collaborative Longitudinal Assessment of Randomised Interventions and Therapies; www.CLARITY-IgAN.org) and holds senior leadership roles in multiple global, late-phase drug registration trials evaluating therapies to prevent kidney failure and cardiovascular disease.

His research has informed more than 30 clinical practice guidelines and consensus statements, and he is actively involved in the development of national and international standards, including for KDIGO and the American Society of Nephrology. A/Prof Neuen has authored over 175 peer-reviewed publications, including works in the New England Journal of Medicine, The Lancet, JAMA, and Nature Medicine. He serves on the editorial boards for flagship journals of the European Renal Association and the American Diabetes Association.

A/Prof Neuen studied medicine at James Cook University (First Class Honours, Academic Medal), holds a Masters in Global Health from the University of Oxford (Clarendon Scholar, top-ranked dissertation), a PhD from UNSW (NHMRC funded), and completed his Postdoctoral Fellowship at Harvard Medical School. A Fellow of both the Royal Australasian College of Physicians and the American Society of Nephrology, his work is supported by the NHMRC, Ramaciotti Foundation and philanthropic sources, and has been recognized through awards including the Royal Society of New South Wales Ida Browne Medal and the American Heart Association's Paul Dudley White International Scholar Award.

Dr Balaji Gummidi is a Senior Project Manager at The George Institute for Global Health India. Dr Gummidi has over 7 years of experience in epidemiological data analysis and effective reporting. He has a blend of experience in project implementation, evaluation, research designs, data analysis, quality control, scientific writing and publications.

Dr Gummidi finished his Bachelor's degree in Dental Surgery at NRT university of health science, completed his Masters of Public Health from Jodhpur National University, Rajasthan and MBA in Hospital Management from GITAM University, Visakhapatnam. He has worked as Research Assistant in Centre for Occupational and Environmental Health, Maulana Azad Medical College and as a Research Fellow under Public Health Foundation of India.

Dr Gummidi has received various prestigious scholarships from Netherlands Institute for Health Sciences (NIHES), Netherlands Fellowship Program (NFP), Vanderbilt-Emory-Cornell-Duke Fogarty Global Health, National Structured Operational Research and Training IniTiative (Sort-IT), American Thoracic Society (ATS).

Dr. Soumyadeep Bhaumik is a medical doctor and international public health research methodologist striving to harness the power of science to drive just transformation for healthier individuals, communities, and nations.

As the Head of the Meta-research and Evidence Synthesis Unit at The George Institute for Global Health, he oversees an agile global team of researchers, specialising in using fit-for-purpose approaches for synthesising evidence to inform policies, practices, and guidelines. He is recognised internationally for his work on evidence synthesis, particularly research priority setting and core outcome sets - both its conduct and methodological aspects. He also works on the moral and epistemological aspects of meta-research in health and medicine with the intent to transform the evidence ecosystem from justice-blind to pro-justice. Soumyadeep also conducts interpretive policy analysis to understand the societal construction and framing of public health problems. As a methodologist, he works in a disease-agnostic manner, although recent work has had a focus on snakebite.

Soumyadeep' s work has impacted the way research is conducted -through the Cochrane Handbook Chapter, which provides guidance on framing the scope of systematic reviews, development of reporting guidelines for research, and through methodological research. His work routinely influences guidelines, and policies of governments and multi-laterals. They have consistently been listed as one of the top 2% lifetime cited researchers (Stanford University analysis in General & Internal Medicine and Public Health field) since 2021.

Karena Conroy leads the Consumer and Community Involvement Program at The George Institute for Global Health, having established this central support structure from the ground up. She is a health research facilitator and occasional researcher, with an educational background in the social sciences, psychology, and a PhD in Health.

Her work focuses on improving and increasing consumer and community involvement in health research across the Institute and the wider health and medical research sector. Karena brings together knowledge and experience from both health research and lived experience of health conditions, enabling her to bridge these perspectives effectively.

Karena is committed to involving community members in meaningful, impactful ways that align with best practice. She is passionate about improving population health and believes that working collaboratively with those affected by health research is key to achieving better outcomes.